06.08.2018 – 09:11 Stada ArzneimittelPress release - STADA becomes Majority Shareholder of BIOCEUTICALS Arzneimittel AG - CEO Claudio Albrecht: "Excellent basis for further strong growth in the biosimilar segment" Press release STADA becomes Majority Shareholder of BIOCEUTICALS Arzneimittel AG CEO Claudio Albrecht: "Excellent basis for further strong growth in the biosimilar segment" Bad Vilbel, August 6, 2018 - After repurchasing the rights to Hedrin® from ... One documentmore
